Entrada Therapeutics Stock Price on July 15, 2024

TRDA Stock  USD 21.52  0.07  0.32%   
If you're considering investing in Entrada Stock, it is important to understand the factors that can impact its price. As of today, the current price of Entrada Therapeutics stands at 21.52, as last reported on the 10th of December, with the highest price reaching 21.79 and the lowest price hitting 21.19 during the day. Entrada Therapeutics appears to be not too volatile, given 3 months investment horizon. Entrada Therapeutics secures Sharpe Ratio (or Efficiency) of 0.22, which denotes the company had a 0.22% return per unit of risk over the last 3 months. By reviewing Entrada Therapeutics' technical indicators, you can evaluate if the expected return of 0.63% is justified by implied risk. Please utilize Entrada Therapeutics' Coefficient Of Variation of 468.48, mean deviation of 2.14, and Downside Deviation of 2.27 to check if our risk estimates are consistent with your expectations.
  
At present, Entrada Therapeutics' Common Stock Shares Outstanding is projected to increase significantly based on the last few years of reporting. The current year's Stock Based Compensation is expected to grow to about 13.8 M, whereas Total Stockholder Equity is forecasted to decline to about 153.3 M. . At present, Entrada Therapeutics' Price Book Value Ratio is projected to increase significantly based on the last few years of reporting. The current year's Price Earnings To Growth Ratio is expected to grow to 0.84, whereas Price To Sales Ratio is forecasted to decline to 3.10. Entrada Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = 0.2177

Best PortfolioBest Equity
Good Returns
Average Returns
Small ReturnsTRDA
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative Returns

Estimated Market Risk

 2.89
  actual daily
25
75% of assets are more volatile

Expected Return

 0.63
  actual daily
12
88% of assets have higher returns

Risk-Adjusted Return

 0.22
  actual daily
17
83% of assets perform better
Based on monthly moving average Entrada Therapeutics is performing at about 17% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Entrada Therapeutics by adding it to a well-diversified portfolio.
Price Book
1.9124
Enterprise Value Ebitda
6.8494
Price Sales
3.7536
Shares Float
18.4 M
Wall Street Target Price
26.4275

Entrada Therapeutics Main Headline on 15th of July 2024

Filed transaction by Entrada Therapeutics Director, Officer: Ceo. Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)

Entrada Therapeutics Valuation on July 15, 2024

It is possible to determine the worth of Entrada Therapeutics on a given historical date. On July 15, 2024 Entrada was worth 17.36 at the beginning of the trading date compared to the closed value of 17.86. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Entrada Therapeutics stock. Still, in general, we apply an absolute valuation method to find Entrada Therapeutics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Entrada Therapeutics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Entrada Therapeutics' related companies.
 Open High Low Close Volume
  17.80    18.00    16.72    17.15    190,486  
07/15/2024
  17.36    18.00    17.18    17.86    168,520  
  18.17    18.17    17.48    17.76    120,689  
Backtest Entrada Therapeutics  |  Entrada Therapeutics History  |  Entrada Therapeutics Valuation   PreviousNext  
Open Value
17.36
17.86
Closing Value
26.04
Upside

Entrada Therapeutics Trading Date Momentum on July 15, 2024

On July 16 2024 Entrada Therapeutics was traded for  17.76  at the closing time. The top price for the day was 18.17  and the lowest listed price was  17.48 . The trading volume for the day was 120.7 K. The trading history from July 16, 2024 was a factor to the next trading day price decrease. The trading price change against the next closing price was 0.56% . The overall trading delta against the current closing price is 9.07% .

Entrada Therapeutics Fundamentals Correlations and Trends

By evaluating Entrada Therapeutics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Entrada Therapeutics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Entrada financial account trend analysis is a perfect complement when working with valuation or volatility modules.

About Entrada Therapeutics Stock history

Entrada Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Entrada is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Entrada Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Entrada Therapeutics stock prices may prove useful in developing a viable investing in Entrada Therapeutics
Last ReportedProjected for Next Year
Common Stock Shares Outstanding33.1 M34.8 M
Net Loss-85.2 M-80.9 M

Entrada Therapeutics Quarterly Net Working Capital

403.73 Million

Entrada Therapeutics Stock Technical Analysis

Entrada Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Entrada Therapeutics technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Entrada Therapeutics trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Price Boundaries

Entrada Therapeutics Period Price Range

Low
December 10, 2024
0.00  NaN%
High

 0.00 

     

 0.00 

Entrada Therapeutics cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.

Entrada Therapeutics December 10, 2024 Market Strength

Market strength indicators help investors to evaluate how Entrada Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Entrada Therapeutics shares will generate the highest return on investment. By undertsting and applying Entrada Therapeutics stock market strength indicators, traders can identify Entrada Therapeutics entry and exit signals to maximize returns

Entrada Therapeutics Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Entrada Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Entrada Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Entrada to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.

Complementary Tools for Entrada Stock analysis

When running Entrada Therapeutics' price analysis, check to measure Entrada Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Entrada Therapeutics is operating at the current time. Most of Entrada Therapeutics' value examination focuses on studying past and present price action to predict the probability of Entrada Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Entrada Therapeutics' price. Additionally, you may evaluate how the addition of Entrada Therapeutics to your portfolios can decrease your overall portfolio volatility.
Fundamental Analysis
View fundamental data based on most recent published financial statements
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities